The Predictive Value of Pretreatment Hemoglobin-to-platelet Ratio on Osteoradionecrosis Incidence Rates of Locally Advanced Nasopharyngeal Cancer Patients Managed with Concurrent Chemoradiotherapy

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2023 Apr 20

PMID 37081475

Authors

Busra Yilmaz

Efsun Somay

Erkan Topkan

Ahmet Kucuk

Berrin Pehlivan

Ugur Selek

Affiliations

Soon will be listed here.

Abstract

Background: This retrospective study aimed to investigate whether the pretreatment hemoglobin-to-platelet ratio (HPR) could predict the risk of osteoradionecrosis (ORN) in patients receiving concurrent chemoradiotherapy (C-CRT) for locally advanced nasopharyngeal carcinoma (LA-NPC).

Methods: ORN cases were reported from the records of LA-NPC patients who had oral examinations before and after C-CRT. The pretreatment HPR values were calculated on the first day of C-CRT. The connection between HPR values and ORN occurrences was determined using receiver operating characteristic curve analysis. The primary endpoint was the relationship between the pretreatment HPR values and post-C-CRT ORN incidence rates, while secondary endpoints included the identification of other putative ORN risk factors.

Results: We distinguished 10.9% incidences of ORN during the post-C-CRT follow-up period among 193 LA-NPC patients. The optimal cutoff for pre-C-CRT HPR was 0.48 that grouped the patients into two HPR groups with fundamentally different post-C-CRT ORN incidence rates: Group 1: HPR ≤ 0.48 (N = 60), and Group 2: HPR > 0.48 (N = 133). The comparative analysis indicated a significantly higher ORN incidence in HPR ≤ 0.48 group (30%; P < 0.001). The other factors associated with meaningfully increased ORN rates included the presence of pre-C-CRT ≥ 5 teeth extractions, mandibular volume receiving ≥ 64 Gy, post-C-CRT tooth extractions, mean mandibular dose ≥ 50.6 Gy, and C-CRT to tooth extraction interval > 5.5 months.

Conclusion: Low pretreatment HPR levels were independently and unequivocally linked to significantly increased incidence of ORN post-C-CRT. Pre-C-CRT HPR levels may be used to estimate the incidence of ORN and be useful for taking preventive and therapeutic measures in these patients such as monitoring oral hygiene with strict follow-up, avoidance of unnecessary tooth extractions, particularly after C-CRT, and use of more rigorous mandibular RT dose limits.

Citing Articles

Diagnostic and Therapeutic Approaches to Jaw Osteoradionecrosis.

Wang Y, Turkstani H, Alfaifi A, Akintoye S Diagnostics (Basel). 2024; 14(23).

PMID: 39682583 PMC: 11640485. DOI: 10.3390/diagnostics14232676.

Topkan's CARWL Index Efficiently Predicts the Radiation-Induced Tooth Loss Rates in Radically Treated Locally Advanced Nasopharyngeal Cancer Patients.

Somay E, Topkan E, Bascil S, Ozturk D, Senyurek S, Durankus N Technol Cancer Res Treat. 2024; 23:15330338241292234.

PMID: 39420731 PMC: 11490988. DOI: 10.1177/15330338241292234.

In regard to Castagnola et al. (doi: 10.1186/s12903-023-03050-7).

Somay E, Topkan E, Selek U BMC Oral Health. 2024; 24(1):1157.

PMID: 39343912 PMC: 11440927. DOI: 10.1186/s12903-024-04823-4.

References

Owosho A, Tsai C, Lee R, Freymiller H, Kadempour A, Varthis S . The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2016; 64:44-51. PMC: 5560021. DOI: 10.1016/j.oraloncology.2016.11.015. View

Lyons A, Ghazali N . Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008; 46(8):653-60. DOI: 10.1016/j.bjoms.2008.04.006. View

Reuther T, Schuster T, Mende U, Kubler A . Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003; 32(3):289-95. DOI: 10.1054/ijom.2002.0332. View

Darby I, Hewitson T . Hypoxia in tissue repair and fibrosis. Cell Tissue Res. 2016; 365(3):553-62. DOI: 10.1007/s00441-016-2461-3. View

Caparrotti F, Huang S, Lu L, Bratman S, Ringash J, Bayley A . Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017; 123(19):3691-3700. DOI: 10.1002/cncr.30803. View

Russo D, Mariani P, Caponio V, Russo L, Fiorillo L, Zhurakivska K . Development and Validation of Prognostic Models for Oral Squamous Cell Carcinoma: A Systematic Review and Appraisal of the Literature. Cancers (Basel). 2021; 13(22). PMC: 8616042. DOI: 10.3390/cancers13225755. View

Epstein J, Rea G, Wong F, Spinelli J . Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg. 1987; 10(1):48-54. DOI: 10.1002/hed.2890100108. View

Yilmaz B, Somay E, Selek U, Topkan E . Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy. Ther Clin Risk Manag. 2021; 17:1113-1121. PMC: 8536877. DOI: 10.2147/TCRM.S334556. View

Madrid C, Abarca M, Bouferrache K . Osteoradionecrosis: an update. Oral Oncol. 2010; 46(6):471-4. DOI: 10.1016/j.oraloncology.2010.03.017. View

10.

Jawad H, Hodson N, Nixon P . A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 2. Br Dent J. 2015; 218(2):69-74. DOI: 10.1038/sj.bdj.2015.29. View

11.

Helvaci M, Aydogan A, Akkucuk S, Oruc C, Ugur M . Sickle cell diseases and ileus. Int J Clin Exp Med. 2014; 7(9):2871-6. PMC: 4211801. View

12.

Marx R, Johnson R . Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987; 64(4):379-90. DOI: 10.1016/0030-4220(87)90136-8. View

13.

Morrish Jr R, Chan E, Silverman Jr S, Meyer J, Fu K, Greenspan D . Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer. 1981; 47(8):1980-3. DOI: 10.1002/1097-0142(19810415)47:8<1980::aid-cncr2820470813>3.0.co;2-y. View

14.

Marx R . Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983; 41(5):283-8. DOI: 10.1016/0278-2391(83)90294-x. View

15.

Delanian S, Lefaix J . The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004; 73(2):119-31. DOI: 10.1016/j.radonc.2004.08.021. View

16.

Dumoulin S, van Maanen A, Magremanne M . Dental prevention of maxillo-mandibular osteoradionecrosis: A ten-year retrospective study. J Stomatol Oral Maxillofac Surg. 2020; 122(2):127-134. DOI: 10.1016/j.jormas.2020.05.022. View

17.

Beech N, Porceddu S, Batstone M . Radiotherapy-associated dental extractions and osteoradionecrosis. Head Neck. 2016; 39(1):128-132. DOI: 10.1002/hed.24553. View

18.

Dhanda J, Pasquier D, Newman L, Shaw R . Current Concepts in Osteoradionecrosis after Head and Neck Radiotherapy. Clin Oncol (R Coll Radiol). 2016; 28(7):459-66. DOI: 10.1016/j.clon.2016.03.002. View

19.

Chrcanovic B, Albrektsson T, Wennerberg A . Dental implants in irradiated versus nonirradiated patients: A meta-analysis. Head Neck. 2014; 38(3):448-81. DOI: 10.1002/hed.23875. View

20.

Moon D, Moon S, Wang K, Weissler M, Hackman T, Zanation A . Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol. 2017; 72:98-103. DOI: 10.1016/j.oraloncology.2017.07.014. View